ACLY and CKD: A Mendelian Randomization Analysis

INTRODUCTION: Adenosine triphosphate-citrate lyase (ACLY) inhibition is a therapeutic strategy under investigation for atherosclerotic cardiovascular disease, nonalcoholic steatohepatitis, and metabolic syndrome. Mouse models suggest that ACLY inhibition could reduce inflammation and kidney fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi-Shemirani, Pedrum, Chong, Michael, Perrot, Nicolas, Pigeyre, Marie, Steinberg, Gregory R., Paré, Guillaume, Krepinsky, Joan C., Lanktree, Matthew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263230/
https://www.ncbi.nlm.nih.gov/pubmed/35812273
http://dx.doi.org/10.1016/j.ekir.2022.04.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263230/
https://www.ncbi.nlm.nih.gov/pubmed/35812273
http://dx.doi.org/10.1016/j.ekir.2022.04.013

Ejemplares similares